Sign Up / Log In
Account
Online Pharmacy
Doctor Services
Health Centre
Bulk Purchase
Corporate
Rilpivirine is commonly used to treat hiv infection
Rilpivirine is a non-nucleoside reverse transcriptase inhibitor (NNRTI) which will help to reduce the viral DNA synthesis, leading to the prevention of viral proliferation and viral death.
Mental disturbances, Central obesity, Hepatotoxicity, Allergic reactions, Immune reconstitution syndrome, Abdominal pain, Dry mouth, Vomiting, Increased cholesterol and triglyceride level, Decreased red blood cells/white blood cells/platelets, Decreased appetite, Drowsiness
Alcohol is not recommended in the first 4 weeks of therapy and it is not advisable to be used as alcohol will further damage the liver caused by Rilpivirine.
Animal studies have not shown any reproductive toxicities but there are limited data on the use of Rilpivirine in pregnant women. Thus, it is not advisable to be used during pregnancy. Please consult your doctor.
Excretion of Rilpivirine has been found in animal milk but it is unknown in human breast milk. An HIV-infected mother is not recommended to breastfeed the baby to prevent transmission and adverse effects of Rilpivirine. Please consult your doctor.
Rilpivirine usually does not affect the ability to drive. Do not drive unless you are feeling well.
Caution use has to be practised in patients with severe or end-stage kidney disease. Please consult your doctor.
Caution use has to be practised in patients with moderate liver impairment. Rilpivirine is contraindicated in patients with severe liver impairment. Please consult your doctor.